Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 25, 823–824 (1 August 2007) | doi:10.1038/nbt0807-823
Positive clinical data in Parkinson's and ischemia buoy gene therapy
Abstract
The rehabilitation of gene therapy is gaining momentum, as positive news on both the clinical and commercial fronts suggests the field is closer than ever to a long-awaited success, particularly for disorders that represent niche, unmet medical needs. With a steady accumulation of positive data in multiple indications, not only are investors and biotech firms showing renewed interest, but also large pharmaceutical companies are back in the game.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
